We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
+4.23%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$910M
AUM Growth
+$303M
(+50%)
Cap. Flow
+$298M
Cap. Flow
% of AUM
32.79%
Top 10 Holdings %
Top 10 Hldgs %
6.34%
Holding
2,256
New
789
Increased
455
Reduced
377
Closed
581
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GXGXU
GX Acquisiton Corp. Unit
GXGXU
|
+$2.63M |
| 2 |
LCAHU
Landcadia Holdings II, Inc. Unit
LCAHU
|
+$2.3M |
| 3 |
HYACU
Haymaker Acquisition Corp. II Unit
HYACU
|
+$1.62M |
| 4 |
GIX.U
GigCapital2, Inc.
GIX.U
|
+$1.35M |
| 5 |
Sarepta Therapeutics
SRPT
|
+$1.35M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.76% |
| 2 | Consumer Discretionary | 1.21% |
| 3 | Technology | 1% |
| 4 | Financials | 0.87% |
| 5 | Industrials | 0.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RRD
1576
CALL
DELISTED
RR Donnelley & Sons Co.
RRD
| $13K | ﹤0.01% |
6,700
-6,400
| -49% | -$21.1K |
|
1577
Chegg
CHGG
$109M
| $12K | ﹤0.01% |
300
-6,696
| -96% | -$252K |
|
1578
HealthEquity
HQY
$8.2B
| $12K | ﹤0.01% |
190
+10
| +6% | +$696 |
|
|
HTT
1579
PUT
High Templar Tech Ltd
HTT
$382M
| $12K | ﹤0.01% |
+1,600
| New | +$11K |
|
1580
Veracyte
VCYT
$4.48B
| $12K | ﹤0.01% |
+413
| New | +$10.3K |
|
1581
Compañía de Minas Buenaventura
BVN
$7.86B
| $11K | ﹤0.01% |
630
-1,892
| -75% | -$30K |
|
|
CTRA
1582
PUT
DELISTED
Coterra Energy
CTRA
| $11K | ﹤0.01% |
500
-100
| -17% | -$2.55K |
|
1583
PUT
Dollar Tree
DLTR
$23.9B
| $11K | ﹤0.01% |
+100
| New | +$10.5K |
|
1584
Ionis Pharmaceuticals
IONS
$9.35B
| $11K | ﹤0.01% |
170
-1,490
| -90% | -$105K |
|
1585
Synaptics
SYNA
$4.36B
| $11K | ﹤0.01% |
+385
| New | +$12.6K |
|
1586
Teradata
TDC
$2.79B
| $11K | ﹤0.01% |
300
-500
| -63% | -$19.5K |
|
|
CCMP
1587
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $11K | ﹤0.01% |
100
| – | – |
|
1588
PUT
Centene
CNC
$31.3B
| $10K | ﹤0.01% |
200
-5,200
| -96% | -$281K |
|
1589
PUT
Dropbox
DBX
$7.04B
| $10K | ﹤0.01% |
+400
| New | +$9.24K |
|
1590
F5
FFIV
$22.2B
| $10K | ﹤0.01% |
+70
| New | +$10.5K |
|
1591
Ingredion
INGR
$6.42B
| $10K | ﹤0.01% |
120
| – | – |
|
1592
Nu Skin
NUS
$251M
| $10K | ﹤0.01% |
+200
| New | +$10.2K |
|
|
TLRD
1593
CALL
DELISTED
Tailored Brands, Inc.
TLRD
| $10K | ﹤0.01% |
1,700
-3,300
| -66% | -$22.9K |
|
|
TECD
1594
PUT
DELISTED
Tech Data Corp
TECD
| $10K | ﹤0.01% |
100
-1,100
| -92% | -$112K |
|
1595
Bio-Rad Laboratories Class A
BIO
$8.52B
| $9K | ﹤0.01% |
+30
| New | +$8.98K |
|
1596
G-III Apparel Group
GIII
$1.51B
| $9K | ﹤0.01% |
300
-2,028
| -87% | -$69.2K |
|
1597
Incyte
INCY
$23.9B
| $9K | ﹤0.01% |
110
-2,285
| -95% | -$183K |
|
1598
PUT
CarMax
KMX
$8.42B
| $9K | ﹤0.01% |
+100
| New | +$7.82K |
|
|
AD
1599
PUT
Array Digital Infrastructure
AD
$3.04B
| $9K | ﹤0.01% |
200
-700
| -78% | -$32.7K |
|
1600
United Therapeutics
UTHR
$26.5B
| $9K | ﹤0.01% |
110
-688
| -86% | -$64.3K |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Walleye Capital held 2,256 positions worth $910M, up 50% from $607M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Walleye Capital deployed $298M of net new capital in Q2 2019, opening 789 new positions and adding to 455 existing holdings. Its largest new stake was GX Acquisiton Corp. Unit: 261,600 shares worth $2.63M.
By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 1.3% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half, an estimated $1.87M trimmed.
- Walleye Capital's largest Q2 2019 buy was GX Acquisiton Corp. Unit: 261,600 shares worth $2.63M.
- Walleye Capital added most to Cronos Group in Q2 2019, an estimated $727K increase.
- Walleye Capital's biggest Q2 2019 reduction was Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half, cutting an estimated $1.87M.
- Walleye Capital fully exited Pivotal Acquisition Corp. in Q2 2019, selling an estimated $1.27M.
- Walleye Capital's ten largest holdings make up 6.3% of its $910M portfolio in Q2 2019.
- Walleye Capital opened 789 new positions and closed 581 in Q2 2019.
- Walleye Capital's portfolio value rose 50% quarter-over-quarter to $910M.
Based on Walleye Capital's 13F filing for Q2 2019, filed 14 Aug 2019.